IL15 and uterine corpus endometrial carcinoma: Pan-cancer patients with uterine corpus endometrial carcinoma, sarcoma, cholangiocarcinoma, and esophageal adenocarcinoma owned the highest gene alteration rate of IL-15 (>2%) compared with the primary type in the cBioPortal database (Figure 4A).